The Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc. for $137 Million
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.spilmanlaw.com/Spilman/media/PDF/2023-06-01-Chemours-Sale.pdf?ext=.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (3)
Alternatively, you can try searching for similar contracts:
